TRML: Tourmaline Bio, Inc. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Biofarmatsevtika sohasiga kirishning yuqori to'sig'i qimmat tadqiqotlar va qat'iy tartibga soluvchi nazorat bilan bog'liqdir. PEG o'sish aksiyalari ko'rsatkichi biznesning baholanish dinamikasini foyda bilan nisbatda namoyish etadi, bunda 0.00 darajasi ushbu metrikaning joriy qiymatini aks ettiradi. Tourmaline Bio, Inc. (TRML) maqsadli yallig'lanish terapiyasiga e'tibor qaratgan holda yopiq patent perimetrini yaratmoqda va yagona dori nomzodi uchun sinovlar yakunlangach, soha gigantlari tomonidan sotib olinishni maqsad qilgan.
Tourmaline Bio, Inc. (TRML) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Tourmaline Bio, Inc.|TRML - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi tourmalinebio.com|TRML - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Tourmaline Corp|TRML - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori Tourmaline Bio|Shoshilinch likvidlik tourmalinebio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
TRML - Sof daromad|Prognoz qilingan kelajakdagi foyda Tourmaline Bio, Inc.|TRML - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori Tourmaline|TRML - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Tourmaline Corp|TRML - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Tourmaline Bio|TRML - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi tourmalinebio.com|TRML - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Tourmaline Bio, Inc.
Kompaniyaning umumiy tahlili:TRML - Tourmaline Bio Inc
Tourmaline Bio, Inc. (TRML) immunologik ekotizimining rivojlanishi FDA protokollariga qat'iy rioya qilishga bog'liq bo'lib, bu PEG ko'rsatkichini o'sish potentsialini baholashning asosiy vositasiga aylantiradi. Ushbu metrika joriy P/E ko'rsatkichini foyda o'sish sur'ati bilan solishtiradi: birdan past qiymat aktivning kengayishiga nisbatan qadrsizlanganligini anglatadi va noyob terapiya usullarini kengaytirishda biznes modelining barqarorligini tasdiqlaydi.
Tourmaline Bio, Inc. kimlar bilan raqobatlashadi
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|DNTH: Narx-foyda va o‘sish multiplikatori|Pharvaris Pharma - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|abcellera.com (ABCL) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda precigen.com (PGEN)|Narx-foyda va o‘sish multiplikatori PHAR|PEG multiplikatori Nektar Therapeutics Inc|Narxning foydaga va o‘sish sur’atiga nisbati Upstream Bio Corp (UPB)|ZBIO (Zenas Corp) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Immunome, Inc. IMNM|GOSS - Narx-foyda va o‘sish multiplikatori|KalVista Pharmaceuticals, Inc. - PEG multiplikatori|SEPN - PEG multiplikatori|Pieris Pharmaceuticals Inc (PVLA) - Narxning foydaga va o‘sish sur’atiga nisbati|SVRA (Savara Pharma) - Narxning foydaga va o‘sish sur’atiga nisbati|RIGL (Rigel Pharmaceuticals) - PEG multiplikatori|anaptysbio.com (ANAB) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Astria Therapeutics, Inc. (ATXS)|enGene Holdings Inc - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori RAPT (RAPT Therapeutics, Inc.)|Aerovate Therapeutics, Inc. (JBIO) - O‘sish sur’atiga tuzatilgan narx-foyda|ACRS: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti KYTX (kyvernatx.com)|TLSA: PEG multiplikatori|CABA (Cabaletta Bio Inc.) - Narxning foydaga va o‘sish sur’atiga nisbati|VTYX (Ventyx Bio) - PEG multiplikatori|Theratechnologies, Inc (THTX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Avalo Therapeutics, Inc (AVTX)|ELDN - O‘sish sur’atiga tuzatilgan narx-foyda|Agenus Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti CLYM|Zura Bio Limited - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati aTyr Pharmaceuticals ATYR|adagene.com (ADAG) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti IMA|STTK (Shattuck Labs Inc) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Equillium Bio (EQ)|Narx-foyda va o‘sish multiplikatori CNTB (Connect Biopharma)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati immunic-therapeutics.com|Atara Bio - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati IFRX (InflaRx NV)|XFOR - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACET (Adicet Bio)|celularity.com (CELU) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori INmune Bio Corporation|Narxning foydaga va o‘sish sur’atiga nisbati Barinthus Biotherapeutics|Narxning foydaga va o‘sish sur’atiga nisbati KZR|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|AKTX: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti QTTB|GeoVax Labs, Inc. - PEG multiplikatori|EDSA - PEG multiplikatori|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|Carisma Therapeutics Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati XTL Biopharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori Bolt Bio (BOLT)|PEG multiplikatori HCWB|PEG multiplikatori aptevotherapeutics.com (APVO)|AIM ImmunoTech - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ADTX|GRI Bio Corp - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati XORTX Corp XRTX|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori revbiosciences.com|Narxning foydaga va o‘sish sur’atiga nisbati Indaptus Therapeutics, Inc.|Narx-foyda va o‘sish multiplikatori Scinai Immunotherapeutics Ltd (SCNI)|Narx-foyda va o‘sish multiplikatori CALI (CalciMedica, Inc.)|PEG multiplikatori affimed.com (AFMD)|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|IGM Bio - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda iTeos Therapeutics Inc|OCEA (Ocean Bio) - Narx-foyda va o‘sish multiplikatori|TCBP: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
